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Tuesday, March 8, 2011 415afree Ca2þ range of 0-500mM.The sigmoidal dose-response curve yields an EC50
of 1.4550.44 mM (n=10) and Po saturates at ~10 mM Ca
2þ. The gating model
describes the kinetic behaviour using a minimum of three open and closed states
and incorporates constitutive (unliganded) gatingwhile also revealing very brief
closings suggestive of events similar to C-type inactivation in Kþ channels.
Novel detailed burst analysis of RyR2 elucidates its ligand-bound gating kinet-
ics. The model was further validated by simulation of single channel data. This
model provides a firmplatform for further analysis of the effects of physiological
regulatory factors and dissecting the mechanistic nature of the perturbations in
mutant channels causing cardiovascular pathology. Supported by the British
Heart Foundation.
2245-Pos Board B231
Trans Complementation with the Common G1885E Polymorphism Atten-
uates Mutant RyR2 L433P Channel Dysfunction
Aaron I. Clack, N. Lowri Thomas, Nicole C. Silvester,
Steven R. Barberini-Jammaers, F. Anthony Lai, Christopher H. George.
A channelopathic Leu433Pro (L433P) mutation in the cardiac ryanodine recep-
tor (RyR2) alters intracellular Ca2þ handling and is associated with malignant
arrhythmia. This mutation is reported to exclusively co-inherit with a common
single nucleotide polymorphism (SNP) Gly1885Glu (G1885E) present on the
same allele (i.e. in cis). We investigated the functional impact of the G1885E
SNP on L433P channels. RyR2-null HEK cells were used as the background
for the systematic expression of homo- and heteromeric RyR2 channels com-
posed of recombinant wild-type (WT) subunits, and those containing L433P
and G1885E substitutions. Homomeric G1885E channels were functionally
normal, but Ca2þ handling abnormalities associated with the L433P mutation
were exacerbated by complementation with the G1885E in cis. At the cellular
level, channel dysfunction manifested as reduced caffeine-evoked Ca2þ re-
lease and decreased ER Ca2þ store content. These findings suggest that al-
though L433P is not a typical gain-of-function mutation it augments basal
channel activity. Co-expression of L433P subunits with those containing
G1885E (i.e. in trans complementation) attenuated L433P mutant channel dys-
function. Cells expressing heteromeric assemblies of L433P and G1885E sub-
units exhibited caffeine-activation profiles, homeostatic and post-activation
Ca2þ fluxes and ER Ca2þ loads that were comparable to those typical of
WT channels. Our data show that the genotype, allelic distribution and the re-
sultant mode of L433P and G1885E channel assembly (i.e. cis or trans subunit
complementation) has divergent effects on RyR2 channel (dys)function. The
G1885E SNP may be a complex determinant of channel behaviour in situ
and the potential therapeutic benefits of normalising mutant channel dysfunc-
tion via trans-complementation strategies should be further explored.
2246-Pos Board B232
Differently from S165F, Y141H Mutation of Junctophilin-2 affects
Calcium Signaling in Skeletal Muscle
Jin Seok Woo, Keon Jin Lee, Jianjie Ma, Eun Hui Lee.
Junctophilins (JPs) play an important role in the formation of junctional mem-
brane complexes in muscle cells by physically linking the transverse-tubule and
sarcoplasmic reticulum (SR) membranes. In humans with hypertrophic cardio-
myopathy (HCM), mutations in JP2 are associated to altered Ca2þ signaling in
cardiomyocytes. One of the HCM-related JP2 mutants, S165F also induces
both hypertrophy and altered intracellular Ca2þ signaling in skeletal myotubes.
Here, we tried to identify the dominant negative role of another HCM-related
JP2 mutation, Y141H, in primary mouse skeletal myotubes in order to examine
the effects of Y141H on skeletal muscle function. Consistent with S165F-
expressing skeletal myotubes, over-expression of Y141H led to a significant in-
crease in myotube diameter and resting cytosolic Ca2þ concentration. Immuno-
blot assays suggested that the increased resting cytosolic Ca2þ concentration is
possibly due to the increased expression level of an extracellular Ca2þ-entry
channel, Orai1. Unlike S165F, single myotube Ca2þ imaging experiments
with Y141H-expressing myotubes showed a reduction in the gain of
excitation-contraction coupling without an alteration in both ryanodine
receptor1-mediated Ca2þ release from the SR and the amount of SR Ca2þ.
Therefore, the hypertrophy in the Y141H-expressing skeletal myotubes would
be differently progressed from that in the S165F-expressing skeletal myotubes.
2247-Pos Board B233
Orai1 and STIM1 Expression during Mouse Skeletal Muscle Cell
Differentiation
Keon Jin Lee, Jin Seok Woo, Eun Hui Lee.
In skeletal msucle, stromal interaction molecule 1 (STIM1) is the calcium sen-
sor of sarcoplasmic reticulum and Orai1 is an extracellular Ca2þ-entry channel.
These two proteins are known to be components of store-operated Ca2þ-entry
(SOCE) in skeletal muscle. Here, we examined expression of STIM1 and Orai1during skeletal muscle cell differentiation. During differentiation of primary
mouse skeletal myoblasts to myotubes, Orai1 expression was gradually in-
creased until differentiation day 2 and kept at a certain level on further days
of differentiation. STIM1 expression was increased during differentiation. Im-
munocytochemistry of myoblasts and myotubes with anti-STIM1 and anti-
Orai1 antibodies showed that STIM1 and Orai1 were colocalized all over the
cells except for nucleus parts during differentiation. These results suggest
that SOCE by STIM1 and Orai1 plays a certain role in skeletal muscle
differentiation.
2248-Pos Board B234
Galectin-3 Secreted by Human Umbilical Cord Blood-Derived Mesenchy-
mal Stem Cells Reduces Amyloid-Beta42 Neurotoxicity In Vitro
Ju-Yeon Kim, Dong Hyun Kim, Dal-Soo Kim, Ji Hyun Kim,
Sang Young Jeong, Hong Bae Jeon, Eun Hui Lee, Yoon Sun Yang, Wonil Oh,
Jong Wook Chang.
In this study, we found that expression and secretion of galectin-3 (GAL-3)
were upregulated by amyloid-b42 (Ab42) exposure in human umbilical cord
blood-derived mesenchymal stem cell (hUCB-MSC) without cell death.
Ab42-exposed rat primary cortical neuronal cells co-treated with recombinant
GAL-3 were protected from neuronal death in a dose-dependent manner.
hUCB-MSCs were cocultured with Ab42-exposed rat primary neuronal cells
or the neuroblastoma cell line, SH-SY5Y in a Transwell chamber. Coculture
of hUCB-MSCs reduced cell death of Ab42-exposed neurons and SH-SY5Y
cells. This neuroprotective effect of hUCB-MSCs was reduced significantly
by GAL-3 siRNA. These data suggested that hUCB-MSC-derived GAL-3 is
a survival factor against Ab42 neurotoxicity.
2249-Pos Board B235
Rapamycin is a Deceptive Tool for Probing Functional Interactions
Between FK506-Binding Proteins and Ryanodine Receptors
Elisa Venturi, Samantha J. Pitt, Mano Sitsapesan, Elena Galfre´,
Rebecca Sitsapesan.
Although dissociation of FKBP12/FKBP12.6 from RyR channels is widely ac-
cepted to increase open probability (Po) and induce sub-conductance gating,
these effects are not observed by all investigators. Since rapamycin is fre-
quently used to dissociate FKBP12/FKBP12.6 from RyR channels, we exam-
ined whether rapamycin itself could affect RyR function. When rabbit
skeletal SR vesicles were pre-treated with 20 mM rapamycin, the Po of
RyR1, in the presence of 10 mM cytosolic Ca2þ, was significantly higher
than the Po of channels that had not been exposed to rapamycin
(0.15050.055 vs 0.01650.005; SEM; n=7; p<0.05). Cytosolic addition of
1 mM FKBP12 did not reverse the effects of rapamycin (0.14250.043;
SEM; n=3). Similarly, the Po of RyR2 significantly increased after cytosolic
addition of 20 mM rapamycin in the presence of 10 mM cytosolic Ca2þ, from
0.03950.009 to 0.56450.072 (SEM; n=7; p<0.0001). Again, the effect was
not reversed after perfusing away the rapamycin and after subsequent addition
of 200 nM FKBP12.6. Although FKBP12 and FKBP12.6 were not able to lower
the Po of rapamycin-treated channels, lowering free [Ca2þ] to <1 nM com-
pletely shut all channels demonstrating that sensitivity to Ca2þ was retained.
We observed that rapamycin treatment slightly increased the frequency of re-
solvable sub-conductance gating states (events>3 ms duration) but, for both
RyR1 and RyR2, this appeared to be correlated with elevations in Po. Similarly,
slight changes in sub-conductance state gating after additions of FKBP12/
FKBP12.6 were correlated with Po changes. Our data shows that dissociation
of FKBP12/FKBP12.6 from RyR1/RyR2 does not influence the incidence of
sub-conductance state gating. Moreover, we suggest that the direct actions of
rapamycin on RyR channel gating have led to erroneous conclusions regarding
the effects of FKBP12/FKBP12.6 on RyR channel function.
British Heart Foundation funding
2250-Pos Board B236
Effect of Phosphorylation, Cytoskeleton and FK-506 Binding Protein on
the Gating of Coupled Skeletal Ryanodine Receptors
Jake T. Neumann, Sidney Fleischer, Julio A. Copello.
In skeletal muscle fibers, local Ca2þ sparks and global Ca2þ transients arise
from the synchronous activation of arrays of skeletal ryanodine receptors
(RyR1) in the sarcoplasmic reticulum. Marx et al. (1998) first described that
synchronous Ca2þ signaling in cells could be explained by the coordinated gat-
ing of neighboring RyR1; i.e. coupled gating. We have previously reported that
coupled gating of multiple RyR1 requires luminal Ca2þ as current carrier and
ATP/Mg2þ in the cytosolic solution. As ATP is the most effective nucleotide
for coupled gating in the presence of cytosolic Mg2þ, the role of ATP to mod-
ulate RyR1 as a substrate of protein kinases to phosphorylate the channel or to
stabilize RyR1-RyR1 interactions via the cytoskeleton remains possible.
416a Tuesday, March 8, 2011Consequently, we investigate the role of kinases/phosphatases and cytoskeleton
modulators (colchicine and cytochalasin D) on RyR-mediated Ca2þ leak from
SR microsomes as well as on coupled RyR1. We also investigated role of
FKBP12 in coupled RyR1 gating by adding FKBP12 to partially coupled
RyR1 or rapamycin to coupled RyR1 in planar lipid bilayers. Our results sug-
gest the RyR1-RyR1 interactions that are essential for coupled gating were not
significantly affected by addition of kinases/phosphatases, cytoskeleton modu-
lators or the addition/removal of FKBP12 by rapamycin. Yet, some of the
agents affected the overall activity of the RyR1. (Supported by NIH R01
GM078665).
2251-Pos Board B237
CGP37157 is an Inhibitor of the Sarcoplasmic Reticulum Calcium ATPase
and an Activator of Ryanodine Receptors in Striated Muscle
Jake T. Neumann, Paula L. Diaz-Sylvester, Sidney Fleischer,
Julio A. Copello.
CGP-37157 (CGP), a benzothiazepine derivative of clonazepam, is commonly
utilized as a blocker of the mitochondrial Naþ/Ca2þ exchanger. Yet, evidence
suggests that CGP could also affect other targets, such as L-type Ca2þ chan-
nels and plasmalemma Naþ/Ca2þ exchanger. Here, we tested the possibility of
a direct modulation of ryanodine receptors (RyR) and/or sarcoplasmic reticu-
lum (SR) Ca2þ stimulated ATPase (SERCA) by CGP. SERCA activity was
measured in SR microsomes with a ATP-ase activity assay or Ca2þ loading
in presence of ruthenium red (RyR blocker). The effects of CGP on RyR ac-
tivity were performed in SR microsomes with a Ca2þ leak assay or after re-
constitution of the channels into planar lipid bilayers. CGP inhibited
SERCA-mediated Ca2þ uptake of cardiac and skeletal SR microsomes
(IC50’s = 6.6 and 9.9 mM, respectively). The CGP effects on SERCA activity
correlated with a decreased Vmax of ATPase activity of SERCA-enriched skel-
etal SR fractions without an apparent change in Km. CGP (R 5 mM) also in-
creased RyR-mediated Ca2þ leak from skeletal SR microsomes. Planar bilayer
studies confirmed that both cardiac and skeletal RyR are directly activated by
CGP (EC50’s = 9.4 and 12.0 mM, respectively). In summary, we found that
CPG inhibits SERCA and activates RyR channels. Hence, the action of
CGP on cellular Ca2þ homeostasis reported in the literature of cardiac, skel-
etal muscle as well as other non muscle systems requires further analysis to
take into account the contribution of all CGP-sensitive Ca2þ transporters.
(Supported by NIH R01 GM078665).
2252-Pos Board B238
Tetracaine is a Potent Inhibitor of SR Ca Leak in Ventricular Cardiac
Myocytes
Stephen Shonts.
Tetracaine is commonly used to inhibit RyR-dependent SR Ca leak, however
ability to do so in intact cardiac myocytes has not been fully characterized.
In single RyR channel bilayer a significant portion of leak would not be in-
hibited even by low millimolar concentrations of tetracaine. In this study we
investigated the effectiveness of tetracaine on RYR-dependent SR Ca leak in
ventricular myocytes. Experiments were performed in isolated rabbit myo-
cytes loaded with fluo-4. Myocytes were perfused with 2mM Ca NT with
200mM caffeine in order to increase basal SR Ca leak in the presence of
varying concentrations of tetracaine (1, 10, 30, 100mM). Myocytes were
then rapidly perfused with 0 Na, 0 Ca NT with 1mM tetracaine following
washout with same solution but with varying amounts of tetracaine. SR
Ca leak was quantified as the shift of Ca from the cytosol to the SR upon
blockage of the RyR with high tetracaine. The EC50 for tetracaine is signif-
icantly reduced in intact myocytes compared to single RyR channel. Among
the potential explanations for this effect is the possibility that Ca flux regu-
lation makes the RyR clusters in the SR junction more sensitive to blockage
of release.
2253-Pos Board B239
Tetracaine Inhibits RyRs by Three Mechanisms
Derek R. Laver, Dirk F. vanHelden.
Tetracaine is a tertiary amine local anaesthetic (pKa = 8.5) which induces
closures in RyRs. Tetracaine has been extensively used to study the role of
the SR Ca2þ fluxes in Ca2þ handling in muscle cells. We use single channel
recording of rabbit skeletal and sheep cardiac RyRs in lipid bilayers to iden-
tify three mechanisms for tetracaine inhibition. First, luminal and cytoplasmic
tetracaine induce closed events (~100 ms- slow mechanism). Cytoplasmic/lu-
minal competition indicates a common site for cytoplasmic and luminal ac-
tion. The binding rate decreases with increasing RyR open probability,consistent with a closed state mechanism with no detectable binding to
open channels. At pH 7.4, its voltage-dependence points to a cation binding
site within the bilayer, near its luminal interface. At pH 9.5, the slow mech-
anism is independent of voltage, indicating that it also responds to neutral tet-
racaine molecules. Second, cytoplasmic and luminal tetracaine induce brief
closures (~1 ms- fast mechanism). It is insensitive to the open state of the
RyR, independent of voltage and markedly diminished at pH 9.5 indicating
that it is caused exclusively by tetracaine cations binding outside the trans-
membrane electric field. The action of trans-membrane pH gradients on the
fast mechanism points to a cytoplasmic location for the binding site. Finally,
cytoplasmic tetracaine reduces the ionic conductance of the channel at mM
concentrations. We predict that under diastolic conditions, the slow mecha-
nism (IC50 of ~200 mM) is a more potent form of block than the fast mech-
anism or conduction block (IC50 ~ 2mM) and these mechanisms can explain
the differences in the tetracaine inhibition seen at low and high
concentrations.
2254-Pos Board B240
Slow Diffusion Across Cell Membrane Delays Onset of RyR2-Channel
Block and Ca Wave Suppression by Flecainide in Intact Myocytes
Hyun Seok Hwang, Eleonora S. Galimberti, Bjorn C. Knollmann.RyR2 channel inhibitors
such as flecainide suppress
Ca waves in myocytes and
effectively prevent ventric-
ular arrhythmias in vivo.
Since the RyR2 channel is
located in an intracellular
organelle, the sarcoplasmic
reticulum, differences in
diffusion rates across the
cell membrane and gaining
access to the RyR2 may contribute to variability of drug action in intact myo-
cytes and in vivo. To test this hypothesis, we compared three RyR2 channel in-
hibitors to suppress Ca waves in permeabilized and intact myocytes: flecainide
(Flec:6mM), R-propafenone (R-prop:6mM) and tetracaine (Tetra:50mM). All
three drugs exhibited rapid onset of action in permeabilized myocytes (Figure).
In intact myocytes, only Tetra exhibited rapid onset of action, whereas Flec and
R-prop exhibited significant lag times of 10 min and 5 min, respectively (Fig-
ure). Flec’s slow onset of action in intact myocytes occurred even though its
potency was higher intact (IC50=2mM) than permeabilized myocytes
(IC50=12mM).
Conclusion: Slow diffusion of RyR2 channel blockers such as flecainide across
intact membranes importantly determines the onset of Ca wave suppression,
which has to be taken into account when evaluating drug efficacy in intact my-
oyctes and in vivo.
2255-Pos Board B241
Inhibition of Cardiac Ca2þ Release Channels by Class I Anti Arrhythmic
Drugs as Therapy for Arrhythmia
Divya R. Mehra, Dirk F. vanHelden, Bjorn C. Knollmann, Derek R. Laver.
Catecholaminergic polymorphic ventricular tachycardia (CPVT) is an arrhyth-
mia resulting from mutations in either the cardiac Ca2þ release channel (RyR2)
or calsequestrin. Flecainide is a class-Ic compound that is highly effective in
suppressing arrhythmia in CPVT patients and a calsequestrin-null mouse model
of CPVT. Its efficacy is a combination of reduced membrane excitability via its
known Naþ channel block and stabilisation of SR Ca2þ release by a recently
discovered RyR2 block. Here we report RyR2 blocking kinetics of other class
I anti arrhythmic drugs.
RyR2 was isolated from sheep and human hearts, incorporated in lipid bilayers
and investigated by single-channel recordings in presence of diastolic Ca2þ
(100 nM cytoplasmic, 0.1 mM luminal). The class 1c drugs, propafenone, fle-
cainide and encainide decreased RyR open times (IC50 = 17.35 1.6, 16.75 4
and 22.55 1.2 ı`M respectively) whereas classes Ia and Ib had no significant
effect up to 50 mM.
Blocking kinetics was also measured in fully activated RyR2 (1 mM Ca2þ, 2
mM ATP). All class I drugs tested caused voltage-dependent induction of sub-
conductance states with similar actions from luminal and cytoplasmic sides.
However, class Ic drugs produced subconductances with longer duration and
lower conductance than classes 1a and 1b. These differences may explain the
different efficacy of these drugs to curb Ca2þ release in diastole and prevent
arrhythmia.
